Literature DB >> 7455351

Trichostrongylus colubriformis and Ostertagia sp resistant to levamisole, morantel tartrate and thiabendazole: isolation into pure strain and anthelmintic titration.

H V Whitlock, N C Sangster, M Gunawan, C J Porter, J D Kelly.   

Abstract

Strains of Trichostrongylus colubriformis (designated PF4) and Ostertagia sp (O circumcincta/O trifurcata, designated PF5), with varying degrees of resistance to levamisole, morantel tartrate and thiabendazole were isolated into pure culture. Detailed dose response studies showed that both T colubriformis and Ostertagia sp were highly resistant to levamisole and morantel with low level resistance to thiabendazole. The effective dose required to remove 80 per cent worm burdens (ED80) was calculated for each anthelmintic. For T colubriformis the ED80 for levamisole and thiabendazole were 12.6 and 40.1 mg/kg respectively. For Ostertagia sp, the ED80 for levamisole, thiabendazole and morantel were 20.4, 45.2 and 35.8 mg/kg respectively. The implications of these results are discussed with reference to alternative means of chemical control.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7455351

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  2 in total

1.  Standardization of the egg hatch test for the detection of benzimidazole resistance in parasitic nematodes.

Authors:  Georg von Samson-Himmelstjerna; Gerald C Coles; Frank Jackson; Christian Bauer; Fred Borgsteede; Veli Y Cirak; Janina Demeler; Alison Donnan; Pierre Dorny; Christian Epe; Achim Harder; Johan Höglund; Ronald Kaminsky; Dominique Kerboeuf; Ulla Küttler; Elias Papadopoulos; Janez Posedi; John Small; Marián Várady; Jozef Vercruysse; Nicole Wirtherle
Journal:  Parasitol Res       Date:  2009-05-12       Impact factor: 2.289

2.  Does the in vitro egg hatch test predict the failure of benzimidazole treatment in Haemonchus contortus?

Authors:  Michal Babják; Alžbeta Königová; Michaela Urda Dolinská; Tomas Kupčinskas; Jaroslav Vadlejch; Georg von Samson-Himmelstjerna; Saulius Petkevičius; Marián Várady
Journal:  Parasite       Date:  2021-08-18       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.